This drug approval followed the publication of the EMBARK trial, a randomized phase III trial of biochemically recurrent patients who had high-risk disease, defined by a PSA doubling time (PSADT) ≤9 ...

“She was on chemo, but still remained in very good health, even though she was advanced and metastatic ... a procedure that ...

From Gerry Turner announcing he has cancer to the return of a Chicago Cubs legend’s disease, here’s what’s happening in the ...

Tina Willits, now 53, thought she had just two years to live. Today, she is cancer-free — and she wants the world to know about the treatment that saved her.

Hurley was all too familiar with the administrative burden that prior authorization places on doctors’ offices, often ...

This is the second regulatory designation for dostarlimab in locally advanced dMMR/MSI-H rectal cancer, following Fast Track designation ... assessed by magnetic resonance imaging, endoscopy, PET scan ...

London: GSK plc has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for ...

Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that ...

Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that could help medical professionals better target and treat cancer.

Vitale, 85, had surgery this summer after a biopsy of a lymph node in his neck showed cancer. "SANTA CLAUS came early as Dr Rick Brown called & said that my PET SCAN at 7 AM came back CLEAN OF CANCER ...